Atlas Trials

The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus

Clinical trial NCT04591457 · UNKNOWN

Trial details

NCT number
NCT04591457
Sponsor
Indonesia University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2020-10-01
Primary completion
2021-08-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.